ifosfamide has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 10 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coexistence of Philadelphia chromosome (Ph)-negative, primitive hematopoietic progenitor cells with their malignant counterparts in chronic myelogenous leukemia (CML) has been reported." | 2.69 | Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. ( Burger, KJ; Heinzinger, M; Lange, W; Rosenstiel, A; Scheid, S; Waller, CF, 1998) |
| "Twenty-three patients with chronic myelogenous leukemia in early chronic phase (ECP) and not previously treated with alpha-interferon (IFN-alpha) (10 patients), in ECP but pretreated with IFN-alpha (<12 months) (seven patients) and in late chronic phase (LCP) pretreated with IFN-alpha (>12 months) (six patients) underwent autografting with Philadelphia (Ph) chromosome-negative blood progenitor cells (BPCs) (20 patients), or partially/totally Ph-positive BPCs (three patients), previously mobilized during the early phase of recovery after aplasia induced by intensive chemotherapy." | 2.68 | High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. ( Benvenuto, F; Carella, AM; Carlier, P; Chimirri, F; Dejana, A; Ferrara, RA; Florio, G; Frassoni, F; Gatti, AM; Incagliato, M; Lerma, E; Piaggio, G; Pitto, A; Podestà, M; Pollicardo, N; Prencipe, E; Soracco, M; Valbonesi, M; Vassallo, F; Vimercati, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunbar, CE | 1 |
| Nienhuis, AW | 1 |
| Stewart, FM | 1 |
| Quesenberry, P | 1 |
| O'Shaughnessy, J | 1 |
| Cowan, K | 1 |
| Cottler-Fox, M | 1 |
| Leitman, S | 1 |
| Goodman, S | 1 |
| Sorrentino, BP | 1 |
| Van den Berg, D | 1 |
| Wessman, M | 1 |
| Murray, L | 1 |
| Tong, J | 1 |
| Chen, B | 1 |
| Chen, S | 1 |
| Simonetti, D | 1 |
| King, J | 1 |
| Yamasaki, G | 1 |
| DiGiusto, R | 1 |
| Gearing, D | 1 |
| Reading, C | 1 |
| Carella, AM | 3 |
| Chimirri, F | 1 |
| Podestà, M | 1 |
| Pitto, A | 1 |
| Piaggio, G | 1 |
| Dejana, A | 1 |
| Lerma, E | 1 |
| Pollicardo, N | 1 |
| Vassallo, F | 1 |
| Soracco, M | 1 |
| Benvenuto, F | 1 |
| Valbonesi, M | 1 |
| Carlier, P | 1 |
| Vimercati, R | 1 |
| Prencipe, E | 1 |
| Gatti, AM | 1 |
| Ferrara, RA | 1 |
| Incagliato, M | 1 |
| Florio, G | 1 |
| Frassoni, F | 2 |
| Boqué, C | 3 |
| Petit, J | 2 |
| Sarrá, J | 1 |
| Cancelas, JA | 1 |
| Muñoz, J | 1 |
| Español, JI | 1 |
| de la Banda, E | 1 |
| Aventin, A | 2 |
| Berlanga, J | 1 |
| Ferrá, C | 1 |
| Amill, B | 2 |
| Torrico, C | 1 |
| Azqueta, C | 1 |
| Llucià, M | 1 |
| García, J | 1 |
| Grañena, A | 3 |
| Heinzinger, M | 1 |
| Waller, CF | 1 |
| Rosenstiel, A | 1 |
| Scheid, S | 1 |
| Burger, KJ | 1 |
| Lange, W | 1 |
| Sureda, A | 2 |
| Brunet, S | 1 |
| Martino, R | 1 |
| González, JR | 1 |
| Larriba, I | 1 |
| Blanco, A | 1 |
| Martín-Henao, GA | 1 |
| Sierra, J | 2 |
| Salar, A | 1 |
| Menéndez, B | 1 |
1 review available for ifosfamide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
[Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 1998 |
4 trials available for ifosfamide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; | 1996 |
Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Combined Modality | 1996 |
Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; | 1998 |
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Compo | 1999 |
5 other studies available for ifosfamide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive